Back to Results
First PageMeta Content
B-cell chronic lymphocytic leukemia / Lymphocytic leukemia / Orphan drugs / Leukemia / Chlorambucil / End point of clinical trials / Rituximab / Chemotherapy / Fludarabine / Medicine / Chemistry / Oncology


Microsoft Word - Roche 5-10 obinutuzumabPSD final.docx
Add to Reading List

Document Date: 2015-04-22 23:39:46

Open Document

File Size: 211,24 KB

Share Result on Facebook

City

Trial / /

Company

Medical Oncology Group of Australia / ESC co / MRU co / Private Cancer Physicians of Australia / Lymphoma Australia / Manufacturer Gazyva Roche Products Pty Ltd / IPSOS / Roche Products Pty Ltd. / ITT / Haematology Society of Australia / /

Continent

Australia / /

Country

New Zealand / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

leukemia therapy / /

MedicalCondition

total cumulative illness rating scale / /

MedicalTreatment

Chemotherapy / intravenous infusion / /

Organization

Palestine Liberation Organization / /

Person

Cancer Physicians / /

Position

investigator / /

Product

rela / cyclophosphamide / FS / RO5072759 / CLL11 / /

Technology

Chemotherapy / /

SocialTag